These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that it has submitted to the United States Securities and Exchange Commission ("SEC") a registration statement on Form 20-F...
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER U.S. NEWSWIRES/ VANCOUVER, Jan. 27, 2015 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that the Company's...
ESSA Pharma Inc. ("ESSA" or the "Company") filed its financial and operating results today for the fourth quarter and the year ended September 30, 2014. ESSA's highlights for the fiscal year 2014...
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, Jan. 19, 2015 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") announced today that it has...
ESSA Pharma Inc. ("ESSA" or "the Company") today announced that it has received a receipt for a final prospectus that was filed with securities regulators in British Columbia, Alberta and Ontario...